Regeneron Pharmaceuticals
REGN
#297
Rank
ยฃ58.77 B
Marketcap
ยฃ554.50
Share price
-1.62%
Change (1 day)
-3.31%
Change (1 year)

Market capitalization of Regeneron Pharmaceuticals (REGN)

Market cap: ยฃ58.77 Billion

As of January 2026 Regeneron Pharmaceuticals has a market cap of ยฃ58.77 Billion. This makes Regeneron Pharmaceuticals the world's 297th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regeneron Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ58.77 B-4.87%
2025ยฃ61.77 B-0.97%
2024ยฃ62.38 B-16.94%
2023ยฃ75.10 B15.65%
2022ยฃ64.94 B29.08%
2021ยฃ50.31 B33.04%
2020ยฃ37.81 B19.77%
2019ยฃ31.57 B-1.55%
2018ยฃ32.07 B7.32%
2017ยฃ29.88 B-4.75%
2016ยฃ31.37 B-18.15%
2015ยฃ38.33 B42.03%
2014ยฃ26.99 B62.26%
2013ยฃ16.63 B61.53%
2012ยฃ10.29 B211.91%
2011ยฃ3.30 B73.61%
2010ยฃ1.90 B56.92%
2009ยฃ1.21 B21.46%
2008ยฃ0.99 B4.09%
2007ยฃ0.95 B43.04%
2006ยฃ0.67 B28.77%
2005ยฃ0.52 B94.19%
2004ยฃ0.26 B-41.35%
2003ยฃ0.45 B-11.06%
2002ยฃ0.51 B-39.83%
2001ยฃ0.85 B-1.78%
2000ยฃ0.86 B250.62%
1999ยฃ0.24 B80.23%
1998ยฃ0.13 B-14.65%
1997ยฃ0.16 B-33.34%
1996ยฃ0.24 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Regeneron Pharmaceuticals was reported to be:

ยฃ59.23 Billion
by Nasdaq info icon info icon
ยฃ59.73 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
ยฃ132.82 B 126.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ35.47 B-39.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ18.48 B-68.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ395.37 B 572.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ205.28 B 249.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ85.95 B 46.26%๐Ÿ‡ซ๐Ÿ‡ท France